Erlonat Natco tarceva Price Exporter Buy

Erlonat Erlotinib Tablets Manufactured By Natco India at Wholesale Price

We at erlotinib Price are the reliable suppliers , Dealer n  exporters of Erlonat 100 mg - Erlotinib Tablets manufactured by Natco pharma limited India . Erlonat Tablets by Natco is priced at 1/10 the price of its brand equivalent Tarceva . We are supplying Erlonat  Tablets to Importers, Hospitals & individuals all across the world including countries like USA, UK, 中国大陆,香港散装出口商, Vietnam, Taiwan, Singapore, Japan and other countries. For delivery and discounted price kindly contact us Call: +91 9013793888

Erlonat Natco Erlotinib Product Details:

Brand Name: Erlonat 100 mg
Contents: Erlotinib Hydrochloride
Form: Tablets
Strength: 100 mg
Manufactured By: Natco Pharma Ltd
Country Of origin: India
Shipped From: India
Packing: Pack of 30 tabs

Erlotinib Tablets By Natco India

Erlonat-Erlotinib Tablets belongs to a class of medications called Kinase inhibitors and contains erlotinib. It is used for the treatment of non-small cell lung cancer and in combination with Gemcitabine, is used for the treatment of pancreatic cancer which spreads to adjacent tissues of the body.

The action mechanism of the medicine is as follows:
Functions by blocking the action of an abnormal protein to slow down the growth of cancer cells

Erlonat  Supplied as:

Available in 25 mg, 100 mg & 150 mg tablets

Erlonat Dosage:

Usually 150 mg tablet is administered, at least an hour before or two hours after the ingestion of food, for curing pancreatic non-small cell lung cancer. Erlonat is usually given as 100 mg tablets, at least an hour before or two hours after the intake of food, for curing of pancreatic cancer, in combination with gemcitabine.
Overdose:

Symptoms of overdose may include diarrhea and rash
Precautions and warnings:

The medicine should not be taken without consulting the doctor if the patient has liver disease, lung or breathing problems (other than lung cancer). Do not take aspirin, or products containing aspirin, unless prescribed by the doctor Patient must take Erlonat at substantial time gap, if antacids are also being taken If the patient is allergic to the medicine or any of its constituents, then intake is not suggestible.

Erlonat consumption should avoided if the patient is pregnant or breast feeding the child. Doctor consultation suggested for use of birth control during treatment with Erlonat. It is not yet established whether Erlonat passes into breast milk or not. Drug Interactions
Side effects of the Natco Erlotinib  are as follows:
Breathing Closing of the throat Swelling of the lips, tongue, face or hives Shortness of breath Increased coughing Fever and chest pain Severe or persistent nausea Vomiting and loss of appetite Diarrhea Eye pain or irritation Skin rash, dryness, itching and acne Weakness Blistering and peeling Dry or cracked skin Itching, tenderness or burning of the skin Growth of eyelashes on the inside of the eyelid Unusual bruising or bleeding Note: Erlonat is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.
You are here: